149
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Cytomegalovirus and the Eye

, MBChB, MMed, FCOphth, PhDORCID Icon, , MD & , MD, PhD

References

  • Zhao Q, Li NN, Chen YX, Zhao XY. Clinical features of Cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome and efficacy of the current therapy. Front Cell Infect Microbiol. 2023;13:1107237. doi: 10.3389/fcimb.2023.1107237.
  • Ho M, Invernizzi A, Zagora S, Tsui J, Oldani M, Lui G, et al. Presenting features, treatment and clinical outcomes of cytomegalovirus retinitis: non-HIV patients vs HIV patients. Ocul Immunol Inflamm. 2020;28(4):651–658. doi: 10.1080/09273948.2019.1604003.
  • Shapira Y, Mimouni M, Vishnevskia-Dai V. Cytomegalovirus retinitis in HIV-negative patients – associated conditions, clinical presentation, diagnostic methods and treatment strategy. Acta Ophthalmol. 2018;96(7):e761–e767. doi: 10.1111/AOS.13553.
  • Sadik MT, Aksu Ceylan N, Cebeci Z, Kir N, Oray M, Tugal-Tutkun I. Patterns of cytomegalovirus retinitis at a tertiary referral center in Turkey. Int Ophthalmol. 2021;41(9):2981–2992. doi: 10.1007/s10792-021-01857-3.
  • Takakura A, Tessler HH, Goldstein DA, Guex-Crosier Y, Chan C-C, Brown DM, et al. Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature. Ocul Immunol Inflamm. 2014;22(3):175–182. doi: 10.3109/09273948.2013.866256.
  • Radwan A, Metzinger JL, Hinkle DM, Foster CS. Cytomegalovirus retinitis in immunocompetent patients: case reports and literature review. Ocul Immunol Inflamm. 2013;21(4):324–328. doi: 10.3109/09273948.2013.786095.
  • Zhang J, Kamoi K, Zong Y, Yang M, Ohno-Matsui K. Cytomegalovirus anterior uveitis: clinical manifestations, diagnosis, treatment, and immunological mechanisms. Viruses. 2023;15(1):185. doi: 10.3390/V15010185.
  • Chee SP, Jap A. Presumed Fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146(6):883. doi: 10.1016/j.ajo.2008.09.001.
  • Wang I, Yang BCL, Li KH, Wu JS, Chen SN. CMV retinitis with panretinal occlusive vasculitis. Ocul Immunol Inflamm. 2022;32(5):477–484. doi: 10.1080/09273948.2022.2148113.
  • Schneider EW, Elner SG, Van Kuijk FJ, Goldberg N, Lieberman RM, Eliott D, et al. Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients. Retina. 2013;33(9):1791–1799. doi: 10.1097/IAE.0B013E318285F486.
  • Puri P, Kumar V. Proliferative retinopathy in non-human immunodeficiency virus CMV retinitis. Ocul Immunol Inflamm. 2023;32(5):501–504. doi: 10.1080/09273948.2023.2219311.
  • Alcibahy Y, Panwar N, Malik A, Agarwal A. Cytomegalovirus-associated non-necrotizing retinopathy, occlusive retinal vasculitis, and neovascularization. Ocul Immunol Inflamm. 2024;32(5):529–533. doi: 10.1080/09273948.2024.2325054.
  • Tungsattayathitthan U, Singcanvanit R, Choopong P, Jaru-Ampornpan P, Tesavibul N, Sopitviriyaporn W, et al. Predictors for recurrence of cytomegalovirus retinitis in HIV-negative patients. Ocul Immunol Inflamm. 2023;32(5):493–500. doi: 10.1080/09273948.2023.2170250.
  • von Hofsten J, Zetterberg M. Risk factors for cytomegalovirus retinitis in a national survey in Sweden. Ocul Immunol Inflamm. 2023;32(5):485–492. doi: 10.1080/09273948.2022.2154679.
  • Kumar A, Ausayakhun S, Ausayakhun S, Apivatthakakul A, Liu Y, Snyder BM, et al. Quality of life outcomes among patients being screened for cytomegalovirus retinitis in Thailand. Ocul Immunol Inflamm. 2023;32(5):520–524. doi: 10.1080/09273948.2023.2263091.
  • Kapoor R, Sadda SV, Tyagi M. Suspected retinal toxicity after multiple intravitreal ganciclovir injections in a patient of CMV retinitis. Ocul Immunol Inflamm. 2024;32(5):525–528. doi: 10.1080/09273948.2024.2316754.
  • Sheng Q, Sun Y, Zhai R, Fan X, Ying Y, Kong X. 2% ganciclovir controlled Posner-Schlossman syndrome relapse and reduced the chance of corticosteroid dependence: a large cohort in East China. Ocul Immunol Inflamm. 2023;32(5):505–512. doi:10.1080/09273948.2023.2228404.
  • Ying Y, Sun Y, Sheng Q, Zhai R, Fan X, Kong X. Steroid-dependency in Posner-Schlossman syndrome: a suggested topical 2% ganciclovir and gradual decrement of topical steroid combination therapy from Shanghai PSS study. Ocul Immunol Inflammation. 2023;32(5):513–519. doi: 10.1080/09273948.2023.2251576.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.